m-PEG7-CH2-OH

≥95%

Reagent Code: #106273
fingerprint
CAS Number 1807512-35-1

science Other reagents with same CAS 1807512-35-1

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 354.44 g/mol
Formula C₁₆H₃₄O₈
badge Registry Numbers
MDL Number MFCD28950753
inventory_2 Storage & Handling
Storage 2-8°C, dry, sealed

description Product Description

Used extensively in bioconjugation and drug delivery systems, it serves as a linker or spacer molecule to enhance the solubility and stability of therapeutic compounds. Its hydrophilic polyethylene glycol (PEG) chain improves pharmacokinetics by reducing immunogenicity and prolonging circulation time in the body. Commonly applied in the development of antibody-drug conjugates (ADCs), it helps in attaching cytotoxic drugs to antibodies, ensuring targeted delivery to cancer cells. Additionally, it is utilized in modifying proteins, peptides, and nanoparticles to improve their therapeutic efficacy and reduce aggregation. Its application also extends to surface functionalization in biomedical research, where it is used to create biocompatible coatings for implants and diagnostic tools.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿63,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
m-PEG7-CH2-OH
No image available

Used extensively in bioconjugation and drug delivery systems, it serves as a linker or spacer molecule to enhance the solubility and stability of therapeutic compounds. Its hydrophilic polyethylene glycol (PEG) chain improves pharmacokinetics by reducing immunogenicity and prolonging circulation time in the body. Commonly applied in the development of antibody-drug conjugates (ADCs), it helps in attaching cytotoxic drugs to antibodies, ensuring targeted delivery to cancer cells. Additionally, it is utili

Used extensively in bioconjugation and drug delivery systems, it serves as a linker or spacer molecule to enhance the solubility and stability of therapeutic compounds. Its hydrophilic polyethylene glycol (PEG) chain improves pharmacokinetics by reducing immunogenicity and prolonging circulation time in the body. Commonly applied in the development of antibody-drug conjugates (ADCs), it helps in attaching cytotoxic drugs to antibodies, ensuring targeted delivery to cancer cells. Additionally, it is utilized in modifying proteins, peptides, and nanoparticles to improve their therapeutic efficacy and reduce aggregation. Its application also extends to surface functionalization in biomedical research, where it is used to create biocompatible coatings for implants and diagnostic tools.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...